iCell® Neurons: Bringing Relevant Neuronal Biology to the Bench on SelectScience

Drug Discovery
/ Webinars

iCell® Neurons: Bringing Relevant Neuronal Biology to the Bench
30 Oct 2012

iCell Neurons derived from induced pluripotent stem cells (iPSCs) overcome existing models’ limitations in functionality, purity and reproducibility and offer a virtually unlimited supply of well-characterized cells for drug efficacy screening and safety testing. Importantly, using the iPSC technology to produce neurons enable more biologically relevant disease modeling, improved drug screening strategies, and forward movement toward personalized medicine.

Cellular Dynamics International

Watch Webinar

Show per page

1 of 1 Page 1 Next

Overcoming the Challenges of Sample Preparation and LC/MS/MS Method Development for Clinical Applications	21 May 2013	Read
Improve Efficiency of Variant Screening for Biological Drugs	2 May 2013	Read
Automated TruSeq RNA Sample Preparation from FFPE tissue	21 Dec 2012	Read
Live cell imaging to investigate the regulation of cell division timing	14 Nov 2012	Read
iCell® Neurons: Bringing Relevant Neuronal Biology to the Bench	30 Oct 2012	Read
Do you know what's in your laboratory water?	1 Oct 2012	Read
New Developments in Accelerating the High Content Screening Workflow	9 Aug 2012	Read
Using high-throughput RNAi screening to identify cellular factors involved in host-pathogen interactions	10 Jul 2012	Read
Using Stem Cell-Derived Neurons in High Content Screening Assays for Drug Toxicity	27 Jun 2012	Read
Automating High-Throughput Sample Prep for the Analysis of Complex Diseases Using Next Generation Sequencing	24 Apr 2012	Read